European Finance News

ADVA AG Optical Networking (OJ:ADV) : ADVA OPTICAL NETWORKING REPORTS Q3 2008 FINANCIAL RESULTS IN LINE WITH EXPECTATIONS

🕔11/6/2008 9:33:00 AM

ADVA AG Optical Networking (OJ:ADV) ADVA AG Optical Networking / Quarterly report / Ad hoc: ADVA OPTICAL NETWORKING REPORTS Q3 2008 FINANCIAL RESULTS IN LINE WITH EXPECTATIONS Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article▸

Straumur - Burdaras hf (ICE:STRB) Fitch Downgrades Straumur

🕔11/6/2008 5:21:00 AM

Straumur - Burdaras hf (ICE:STRB) 05 November 2008

Read Full Article▸

Straumur - Burdaras hf (ICE:STRB) An Update On Straumur's Position

🕔11/6/2008 4:21:00 AM

Straumur - Burdaras hf (ICE:STRB) Developments in the global financial markets have adversely impacted most financial institutions, including Straumur, since 30 June. Straumur has taken all reasonable steps to disclose information concerning the impact upon it of these developments to its shareholders and creditors.

Read Full Article▸

FORTIS (EBR:FORB) AllianceBernstein - Subsequent Notice

🕔11/6/2008 4:09:00 AM

FORTIS (EBR:FORB) New transparency legislation was introduced recently, requiring disclosure by Fortis of notifications made by investors to Belgian regulator CBFA (Banking, Finance and Insurance Commission) and to Fortis as prescribed.

Read Full Article▸

FORTIS (EBR:FORB) Notification Ping An - Fortis SA/NV

🕔11/6/2008 4:05:00 AM

FORTIS (EBR:FORB) New transparency legislation was introduced recently, requiring disclosure by Fortis of notifications to Belgian regulator CBFA (Banking, Finance and Insurance Commission) and to Fortis as prescribed.

Read Full Article▸

Bavarian Nordic A/S (CPH:BAVA) Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE®

🕔11/6/2008 3:33:00 AM

Bavarian Nordic A/S (CPH:BAVA) Bavarian Nordic has completed a clinical safety report from a large Phase II study with IMVAMUNE® in HIV infected subjects that confirms the excellent safety profile of IMVAMUNE®. Within the next few days the safety report of this study will be submitted to the FDA and this will trigger a USD 25 million milestone payment under the RFP-3 contract. The clinical safety report constitutes a major part of the data package that will be used to potentially support the use of IMVAMUNE® in a declared emergency.

Read Full Article▸

Ablynx (EBR:ABLX) ABLYNX NV - TRANSPARENCY NOTIFICATION

🕔11/6/2008 3:19:00 AM

Ablynx (EBR:ABLX) Publication of transparency notifications in accordance with Article 14 of the Belgian Act of 2 May 2007 regarding the publication of major shareholdings

Read Full Article▸